Skip to main content
Equibles

Concurrent Investment Advisors, LLC

Position in HUMA — Humacyte, Inc.

CIK 2001015 Tampa, FL
Back to HUMA Full portfolio

Position in HUMA

as of Jun 30, 2026 · filed Jul 27, 2026
Position Value
$53,803
+$14,968 QoQ
Shares Held
68,979
+7.8% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 163 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HUMA Over Time

Shares Held

Position Value (USD)

Derivatives in HUMA

reported options exposure · as of Dec 31, 2024
CallValue
$25,250
CallShares
5,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Concurrent Investment Advisors, LLC holds $48,406,067 across 42 Biotechnology names. HUMA ranks #38 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VKTX
Viking Therapeutics, Inc.
 306,280 $11,947,982
2 ROIV
Roivant Sciences Ltd.
 190,938 $6,757,295
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 10,145 $5,039,325
4 CRSP
CRISPR Therapeutics AG
 90,537 $4,937,887
5 ALNY
Alnylam Pharmaceuticals, Inc.
 7,521 $2,264,046
6 BEAM
Beam Therapeutics Inc.
 63,879 $2,192,326
7 REGN
Regeneron Pharmaceuticals, Inc.
 2,839 $1,770,229
8 EXEL
Exelixis, Inc.
 22,791 $1,240,057

All Filings in HUMA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $53,803 68,979
2026-03-31 $38,835 63,979
2025-12-31 $57,639 59,979
2025-09-30 $103,730 59,615
2025-06-30 $106,830 51,115
2025-03-31 $74,167 43,500
2024-12-31 $25,250 5,000
2024-12-31 $163,115 32,300
2024-09-30 $75,072 13,800